$1.86
-0.07 (-3.63%)
Open$2.05
Previous Close$1.93
Day High$2.05
Day Low$1.81
52W High$14.08
52W Low$1.21
Volume—
Avg Volume47.7K
Market Cap8.84M
P/E Ratio—
EPS$-7.63
SectorBiotechnology
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 6.85M | 7.13M | 6.14M |
| Net Income | -1,263,411 | -1,351,255 | -906,681 |
| Profit Margin | -18.4% | -19.0% | -14.8% |
| EBITDA | -2,085,898 | -2,131,542 | -1,625,986 |
| Free Cash Flow | -871,023 | -1,277,993 | -924,733 |
| Rev Growth | +20.2% | +21.4% | +12.5% |
| Debt/Equity | 0.33 | 0.37 | 0.29 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $266.28 | +0.73% | 74.3 | 468.50B |
| AMGN | Amgen Inc | $418.13 | +0.85% | 25.1 | 219.78B |
| GILD | Gilead Sciences Inc | $152.21 | +0.85% | — | 185.02B |
| VRTX | Vertex Pharmaceuticals Inc | $527.67 | +0.28% | 30.5 | 134.17B |
| REGN | Regeneron Pharmaceuticals | $752.25 | -4.54% | 18.8 | 81.31B |
| ALNY | Alnylam Pharmaceuticals Inc | $255.36 | -0.23% | 41.4 | 33.44B |